# A randomized, double-blind, placebo-controlled trial on the efficacy of tranexamic acid combined with rivaroxaban thromboprophylaxis in reducing blood loss after primary cementless total hip arthroplasty

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/a-randomized-double-blind-placebo-controlled-trial-on-the-efficacy-of-tranexamic/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Arnaud Clavé,Romain Gérard,J. Lacroix,C. Baynat,Marc Danguy des Déserts,Florence Gatineau,Dominique Mottier |
| Citations | 43 |
| DOI | 10.1302/0301-620x.101b2.bjj-2018-0898.r1 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2911521556 |
| PMID | 30700116 |
| Type | article |
| Year | 2019 |

## Paper authors

- [Romain Gérard](https://scholariq.org/researchers/romain-gerard/)

## Paper journal

- [The Bone & Joint Journal](https://scholariq.org/journals/the-bone-and-joint-journal/)

## Paper primary topic

- [Blood transfusion and management](https://scholariq.org/topics/blood-transfusion-and-management/)

## Paper topics

- [Blood transfusion and management](https://scholariq.org/topics/blood-transfusion-and-management/)
- [Hemophilia Treatment and Research](https://scholariq.org/topics/hemophilia-treatment-and-research/)
- [Total Knee Arthroplasty Outcomes](https://scholariq.org/topics/total-knee-arthroplasty-outcomes/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.